Long-acting insulin analogues (KTT12) by all Sub-ICB Locations

Why it matters: NICE recommend that for patients with type 2 diabetes requiring insulin, 'neutral protamine Hagedorn' (NPH) insulin is the preferred starting therapy with insulin, and that the more expensive long-acting insulin analogues (detemir and insulin glargine) can be considered as an alternative in certain circumstances.

Description: Number of prescription items for long-acting human analogue insulins as a percentage of the total number of prescription items for all long-acting and intermediate acting insulins excluding biphasic insulins.


Tagged as: Standard, Cost Saving, Diabetes, NICE (or browse all measures)

Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.